⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4315234 | 1.00 | — | — | |
| SCHEMBL5050528 | 1.00 | — | — | |
| SCHEMBL4320594 | 0.88 | — | — | |
| SCHEMBL5058571 | 0.88 | — | — | |
| SCHEMBL4325916 | 0.88 | — | — | |
| SCHEMBL1224199 | 0.83 | — | — | |
| SCHEMBL262923 | 0.83 | — | — | |
| SCHEMBL3074172 | 0.83 | — | — | |
| SCHEMBL6930223 | 0.81 | — | — | |
| SCHEMBL2111745 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114797808-A | Fluorine-containing liquid chromatography packing for polar drug separation and preparation method thereof | 烟台大学 | 2022-07-29 | — | — | CN | claimed |
| CN-114261039-A | Template passivation process | 广东粤港澳大湾区国家纳米科技创新研究院 | 2022-04-01 | — | — | CN | claimed |
| WO-1997048007-A1 | DIPERSION-PREVENTING PATTERN FOR LIQUID CRYSTAL DISPLAY DEVICE | THE DOW CHEMICAL COMPANY (US) | 1997-12-18 | — | — | WO | claimed |
| US-5691011-A | Dispersion-preventing pattern for liquid crystal display device | THE DOW CHEMICAL COMPANY (US) | 1997-11-25 | — | — | US | claimed |
| CN-114797808-A | Fluorine-containing liquid chromatography packing for polar drug separation and preparation method thereof | 烟台大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-114261039-A | Template passivation process | 广东粤港澳大湾区国家纳米科技创新研究院 | 2022-04-01 | — | — | CN | disclosed |
| US-20090142853-A1 | MICROFLUIDIC SYSTEM AND METHODS | EKSIGENT TECHNOLOGIES, LLC (US) | 2009-06-04 | — | — | US | disclosed |
| EP-1044364-B8 | METHOD FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | AVENTIS PHARMA INC (US) | 2008-01-02 | — | — | EP | disclosed |
| EP-1044364-B1 | METHOD FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | AVENTIS PHARM PROD INC (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007021813-A2 | MICROFLUIDIC SYSTEM AND METHODS | EKSIGENT TECHNOLOGIES, LLC (US) | 2007-02-22 | — | — | WO | disclosed |
| EP-1044364-A4 | METHOD AND REAGENTS FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | AVENTIS PHARM PROD INC (US) | 2004-10-06 | — | — | EP | disclosed |
| US-6599753-B1 | Quantifying a solid-phase reaction; obtain chemical intermediate, incubate with fluorine compound, expose to nuclear magnetic resonance, monitor intensity, compare to control | AVENTIS PHARMACEUTICALS INC. | 2003-07-29 | — | — | US | disclosed |
| US-20010031811-A1 | Durable coating composition, process for producing durable, antireflective coatings, and coated articles | LI HUAWEN (US) | 2001-10-18 | — | — | US | disclosed |
| EP-1044364-A1 | METHOD AND REAGENTS FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | Aventis Pharmaceuticals Products Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| WO-1999031491-A1 | METHOD AND REAGENTS FOR THE QUANTIFICATION OF SOLID-PHASE REACTIONS USING FLUORINE NMR | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-06-24 | — | — | WO | disclosed |
| US-5851840-A | Biotinsilane compounds and a binding matrix containing these compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1998-12-22 | — | — | US | disclosed |
| WO-1997048007-A1 | DIPERSION-PREVENTING PATTERN FOR LIQUID CRYSTAL DISPLAY DEVICE | THE DOW CHEMICAL COMPANY (US) | 1997-12-18 | — | — | WO | disclosed |
| US-5691011-A | Dispersion-preventing pattern for liquid crystal display device | THE DOW CHEMICAL COMPANY (US) | 1997-11-25 | — | — | US | disclosed |